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We generated constitutive knockout mouse models for the α9 and α10 nicotinic
acetylcholine receptor (nAChR) subunits by derivation from conditional knockouts by
breeding with CRE deleter mice. We then backcrossed them onto a C57BL/6J genetic
background. In this manuscript, we report the generation of the strains and an auditory
phenotypic characterization of the constitutive α9 and α10 knockouts and a double
α9α10 constitutive knockout. Although the α9 and α10 nAChR subunits are relevant to
a number of physiological measures, we chose to characterize the mouse with auditory
studies to compare them to existing but different α9 and α10 nAChR knockouts (KOs).
Auditory brainstem response (ABR) measurements and distortion product otoacoustic
emissions (DPOAEs) showed that all constitutive mouse strains had normal hearing.
DPOAEs with contralateral noise (efferent adaptation measurements), however, showed
that efferent strength was significantly reduced after deletion of both the α9 and α10
subunits, in comparison to wildtype controls. Animals tested were 3–8 weeks of age and
efferent strength was not correlated with age. Confocal studies of single and double
constitutive KOs showed that all KOs had abnormal efferent innervation of cochlear
hair cells. The morphological results are similar to those obtained in other strains using
constitutive deletion of exon 4 of α9 or α10 nAChR. The results of our physiological
studies, however, differ from previous auditory studies using a α9 KO generated by
deletion of the exon 4 region and backcrossed onto a mixed CBA/CaJ X 129Sv
background.
Keywords: nicotinic acetylcholine receptor, auditory brainstem response, distortion product otoacoustic
emissions, efferent strength
INTRODUCTION
The α9 and α10 nicotinic acetylcholine receptor (nAChR) subunits are members of the subfamily
I, epithelial nicotinic receptor gene family. The α9 and α10 subunits assemble as a heteromeric
pentamer when heterologously expressed in Xenopus oocytes and in vivo in cochlear hair cells
(reviewed in Elgoyhen and Katz, 2012; Goutman et al., 2015). The α9α10 nAChR is atypical because
both subunits are α subunits. It was proposed that the α10 subunit might act as a structural subunit
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because α10 is necessary but not sufficient to maintain
wildtype electrophysiological activity in heterologous systems
and cochlear hair cells (Plazas et al., 2005). There is no evidence
that either the α9 or the α10 subunit is assembled with another
member of the nAChR gene family in hair cells. Although other
nAChR subunits were localized in the cochlea, there was no
evidence of expression of other neuronal subunits in hair cells
using in situ hybridization (Morley et al., 1998).
The apparent reason why the avian but not mammalian α10
can form a functional homomeric receptor when heterologously
expressed is that the mammalian α10 subunit underwent positive
selection pressure and synonymous substitutions occurred in the
complementary face of the α10 subunit (Lipovsek et al., 2014;
Boffi et al., 2017). The contribution of mammalian α9 and α10
to complementary binding sites is nonequivalent (Boffi et al.,
2017), thus rendering the mammalian α10 incapable of forming a
homomer that conducts current (Franchini and Elgoyhen, 2006;
Lipovsek et al., 2012). In a recent study, it was demonstrated,
however, that both α9 and α10 subunits contribute to the
principal component of the agonist binding site, contradicting
the hypothesis that the α10 is a structural subunit, but confirming
that the integrity of both subunits is necessary for the wildtype
receptor function in mammals (Sgard et al., 2002; Vetter et al.,
2007; Taranda et al., 2009; Boffi et al., 2017).
The α9 and α10 subunits were first identified in in the
olfactory epithelium and embryonic and adult hair cells of the
vertebrate inner ear (Elgoyhen et al., 1994, 2001; Hiel et al., 1996;
Simmons and Morley, 1998, 2011; Morley and Simmons, 2002).
Studies of cochlear hair cells in α9 or α10 knockouts have largely
dominated experimentation of α9α10 in vivo pharmacology and
physiology (Katz et al., 2000; Verbitsky et al., 2000; reviewed
in Elgoyhen and Katz, 2012), in part because the cholinergic
innervation of cochlear outer hair cells (OHC) was already
well-known (e.g., Erostegui et al., 1994; Nenov et al., 1996;
reviewed in Elgoyhen and Katz, 2012) and in part because their
localization was generally thought to be limited to sensory hair
cells. Although not reported to exist in brain, α9 and α10 subunits
are now known to be widely distributed. For example, one or
both subunits have been localized in the pituitary (Elgoyhen
et al., 1994, 2001; Luebke et al., 2005), retina (Smith et al., 2014),
Scarpa’s ganglion (Luebke et al., 2005), immune cells (Peng et al.,
2004; Hao et al., 2011; Koval et al., 2011; St-Pierre et al., 2016),
brain and breast tumors (Russo et al., 2014; Spina et al., 2016),
skin keratinocytes (Chernyavsky et al., 2007; Grau et al., 2007),
colon (Bader and Diener, 2015), renal allografts (Meixner et al.,
2014), and osteoblasts (Zablotni et al., 2015).
It is typically inferred that α10 is present whenever α9 is
detected and that they always assemble, but there are data that
suggest that α7 and α10 could form a receptor (Lips et al.,
2006; Morley et al., 2017). Although α9-containing nAChRs are
ionotropic, they may also mediate metabolic signaling (Richter
et al., 2016; Backhaus et al., 2017; Zakrzewicz et al., 2017).
There is in vivo evidence that α9α10 can also exist in at least
two stoichiometries, (α9)3(α10)2 and (α9)2(α10)3, and that ACh
has an additional low sensitive binding site located at the α9-
α9 interface (Indurthi et al., 2014). It is possible that different
stoichiometries exist in different tissues in vivo (Indurthi et al.,
2014). Thus, there are unanswered questions and there is a need
for further study of the α9 and α10 subunits in diverse tissues.
In the cochlea, the α9α10 nAChR mediates the effects of
the medial olivocochlear (MOC) efferent pathway. This pathway
regulates the auditory afferent input to the brain by reducing
the gain produced by OHC via release of acetylcholine (Fuchs,
2014; Guinan, 2014). Earlier studies of mice lacking either a
functional α9 or α10 subunit showed that the MOC terminals
were larger than normal and that there was a reduction in the
MOC suppression of cochlear responses (Vetter et al., 1999,
2007). Although significant, the phenotype produced in these
knockouts was much less severe than previous studies where
MOC fibers were ablated. Neither the α9 or α10 deletion has
any effect on cochlear base line sensitivity, or demonstrate a
decrease in tone detection and intensity discrimination in quiet
and continuous background noise, as has been shown for mice
with MOC pathway lesions (May et al., 2002; Vetter et al., 2007).
Deletion of both α9 and α10 subunitsmay be necessary to observe
a more severe phenotype.
In this manuscript we report the generation of conditional
and constitutive KOs for the α9 and α10 subunits of the nAChR
gene family on a C57BL/6J background. In the α9 KO, exons
1-2 were deleted and in the α10 KO, exons 1–3 were deleted.
ABRs and DPOAEs in the α9 and α10 subunit constitutive KOs
were normal. Although there were no significant differences in
the ABR responses to noise, deletion of both genes resulted in
less suppression of DPOAEs with contralateral noise. Confocal
analysis of the cochlear innervation of hair cells showed aberrant
innervation patterns.
MATERIALS AND METHODS
Generation of the α9 Mutants (Knockouts)
The cloning and the initial generation of themice were conducted
byGenoway, Inc. (Lyon, France). 10.5 kb ofmouse genomicDNA
encompassing the α9 subunit gene region surrounding exons 1
and 2 on chromosome 5 were isolated from the 129Sv/Pas genetic
background and fully sequenced.
The targeting strategy for the generation of the CHRNA9
knockout is shown in Figure 1. Exons 1 and 2 of CHRNA9 were
deleted and their flanking intronic sequences were replaced by
a validated FRT-neomycin-FRT-loxP cassette at the 3′ end and a
single loxP site in the 5′ direction, which effectively eliminated the
translation of any truncated form of the gene. The distal loxP site
was positioned upstream of exon 1within the promoter sequence.
A 7,315 bp positive control (MPB1-C+) and 16,500 bp targeting
vector (MOB1-HR) were constructed and validated. Neomycin
(neo) was used as the positive selection marker. The targeting
vector used the Diphtheria Toxin A (DTA) as a negative selection
marker. Functionality of the loxP and FRT sites was confirmed by
transforming E. coli with the targeting vector and PCR using the
reverse primer GGACCCACAGAATGAACTGAGTTGACC and
forward primer GGTACGCATCGTGCCAAGTTTGG, which
were located downstream of the neomycin cassette and upstream
of the loxP site, respectively.
The targeting vector was linearized with Nrul and the
construct was transfected into ES cells according to standard
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FIGURE 1 | The targeting strategy for the generation of the CHRNA9 knockout. Boxes represent exons. Solid line represents intronic sequences. LoxP and FRT
elements are shown as blue and red triangles, respectively. Neo and DTA boxes represent the neomycin positive selection cassette and the Diphtheria Toxin A
negative selection cassette. The constitutive KO was generated by breeding the floxed nAChR α9 heterozygous mice with Cre-expressing mice.
electroporation procedures. Two hundred and nine isolated
clones were initially screened by PCR to test for homologous
recombination at the 3′ end with the primer sequences CCAGTC
ATAGCCGAATAGCCTCTCCAC/TGTCGAAGGGGAAAT
AGGTGACATCC. Ten positive clones were expanded and the
3′ homologous recombination confirmed for the 10 clones with
PCR. Six correctly targeted ES clones were verified by Southern
blot at the 5′ and 3′ sides (Figure 2) and selected for blastocyst
injection.
Two clones produced surviving chimeras. Two male (agouti)
chimeras were chosen for breeding to C57BL/6J animals to
produce the F1 generation. Seven chimeras derived from one ES
cell line transmitted the mutation successfully. One heterozygote
male (50957) and one heterozygous female (50958) from the F1
generation were verified by Southern blot (Figure 3) and chosen
for breeding.
The floxed region (exons 1–2) was excised by mating the
heterozygous F1 mice with C57BL/6J Cre deleter mice. The
Cre-mediated excision event was confirmed by PCR using
the primer sequences CCAGTCATAGCCGAATAGCCTCTC
CAC/TGTCGAAGGGGAAATAGGTGACATCC to detect the
recombination event. Three of the resulting pups from this N2
generation yielded an amplification product corresponding to the
excised allele and no amplification product for a PCR-specific for
the recombined non-excised allele, confirming the excision event,
and indicating that they were heterozygous for the constitutive
allele. Two heterozygous N2mice and three N2 knockout animals
were analyzed by Southern blot at the 3′ end (Figure 4) and their
genotypes confirmed.
The potential founders were transferred to the Boys Town
National ResearchHospital (BTNRH). The constitutive knockout
line was established from #11862 (see Figure 4). The conditional
knockout line was established from #11625 (see Figure 4).
The neomycin cassette was removed by breeding to C57BL/6J
mice expressing FLP recombinase (Jackson Labs). Both the
constitutive and conditional lines were backcrossed to >99%
congenicity on the C57BL/6J background using MAXBAX
(Charles River, Troy NY).
Generation of the α10 Conditional and
Constitutive Mutants (Knockouts)
The cloning and the initial development of the mice were
conducted by Genoway, Inc. (Lyon, France). Twelve kb of
mouse genomic DNA encompassing the α10 subunit gene region
surrounding exons 1-3 on chromosome 7 were isolated from the
129Sv/Pas genetic background and fully sequenced.
The targeting strategy for the generation of CHRNA10
knockout is shown in Figure 5. Exons 1–3 of CHRNA10 were
deleted and their flanking intronic sequences were replaced by
a validated FRT-neomycin-FRT-loxP cassette at the 3′ end and a
single loxP site in the 5′ direction, which effectively eliminated the
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FIGURE 2 | (A) The schemata for the endogenous and recombined α9 nAChR loci. (B) The Southern blot analysis for 5′ and 3′ homologous recombination in ES cells
(α9 nAChR). The genomic DNA of the 10 tested ES cell clones was compared with wild type DNA from 129ES. Genomic DNA was digested with StuI. The digested
DNA was blotted on nylon membrane and hybridized with either an internal 593 bp 5′ probe (5I-A) or the external 378 bp 3′ probe (3E-J) to screen for 5′ and 3′
homologous recombination. The internal 593 bp 5′ probe was generated by PCR on genomic DNA using the primer pair CTAAGGTGGCAGCAGAATGGAGTT
CC/GCACGGGTACAAGGGTGAAGATGC. The 5′ probe hybridized downstream of the 5′ homology sequence of the targeting vector, which also allowed detection of
the ES cell clones in which the targeting vector was integrated in a non-homologous manner. The 378 external bp 3′ probe was generated by PCR on genomic DNA
using the primer pair ACAGAATGCACTTTGAAAAGTC/CTCAAGAAGCAAAAAACAGC. The expected size of the WT allele was 11,458 bp and the recombined allele
4,138 bp with the 5′ probe and 11,458 and 4,911 bp, respectively, with the 3′ probe. Cell clones GC2, HA11, HB9, HC9, IA7, and KB3 all showed WT and
recombined signals of similar intensity and were chosen for blastocyst injection.
translation of any truncated form of the gene. The distal loxP site
was positioned upstream of exon 1within the promoter sequence.
A 7,866 bp positive control vector (MPB2-C+) and a
16,602 bp targeting vector (MOB2-HR) were constructed and
validated. Neomycin (neo) was used as the positive selection
marker. The targeting vector used the Diphtheria Toxin A
(DTA) as a negative selection marker. Functionality of the
loxP and FRT sites was confirmed by transformed E. coli
with the targeting vector and PCR using the reverse primer
TGACTCAGCTCACTCCCATGAAGACG and forward primer
GCTGAGCGTCAAATGGGAAGGC, which were located
downstream of the neomycin cassette and upstream of the loxP
site, respectively.
The targeting construct was linearized with Nrul and
transfected into ES cells according to standard electroporation
procedures. A total of 352 clones were isolated and 179 were
screened with PCR at the 3′ end of the targeting vector using
the primer sequences TGACTAGGGGAGGAGTAGAAGGTG
GC/GGTTTGAGGTCAGAAGTGCTGGTCC. Ten clones were
selected for analysis by Southern blot at both the 5′ and 3′ sides
(Figure 6). Three clones were selected for blastocyst injection
(see Figure 6). Three clones produced surviving six chimeric
animals. Twomale highly chimeramice were chosen for breeding
to C57BL/6J females to produce the F1 generation. Three (agouti)
females in the F1 generation carried the recombined allele.
Recombination in two females (#79717 and #79718) was verified
by Southern blot (Figure 7) and chosen for breeding.
The floxed region (exons 1–3) was excised by mating the
heterozygous F1 mice with C57BL/6J Cre deleter mice. The
Cre-mediated excision event was confirmed by PCR. Four mice
from the F1 generation and 29 pups from the N2 generation
were tested with PCR and yielded an amplification product
corresponding to the excised allele, indicating that they were
heterozygous for the constitutive allele. Southern blot analysis
(Figure 8) confirmed the PCR results. Five male heterozygous
recombinedmice (#29211, #38057, #38059, #38366, #38049), four
female heterozygous recombined mice (#38065, #38368, #38371,
#38053), two male heterozygous knockouts (#38365, #38367)
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FIGURE 3 | (A) The schemata for the endogenous and recombined α9 nAChR loci. (B) The Southern blot analysis of the α9 F1 generation. A 90% chimeric male
mouse from clone HA11 was mated with C57BL/6J females. The genomic DNAs of two resulting agouti pups (#50957 and #50958) were compared to C57BL/6J
wildtype DNA. StuI digested DNAs were blotted on nylon membrane and hybridized with the external 3′ probe (3E-J) to validate the heterozygosity of the nAChR α9
gene mutation.
and two female heterozygous knockouts (#29213, #38370) and
two incomplete excised heterozygotes were identified (#38051,
#38056).
The potential founders were transferred to BTNRH. The
constitutive knockout line was established from #38367 (see
Figure 8). The conditional knockout line was established from
#38368 (see Figure 8). The neomycin cassette was removed
by breeding to C57BL/6J mice expressing FLP recombinase
(Jackson Labs). Both the constitutive and conditional lines were
backcrossed to >99% congenicity on the C57BL/6J background
using MAXBAX (Charles River, Troy NY).
Experimental Animals
The physiological and morphological studies performed on
wildtype (WT) and KO mice, which were all backcrossed to
congenicity before use. Single knockouts were obtained from
heterozygote females and either heterozygote or knockout males.
Double knockouts were obtained from female mice heterozygote
for α9 and α10 and male mice heterozygote for α9 and α10 or
double α9α10 KOmales.WT controls were from the same colony
and obtained by mating heterozygote females with heterozygote
or WT males or WT females with heterozygote males. The
animals were bred and genotyped at BTNRH and shipped via
air courier to the Kresge Institute or Washington University after
weaning. Animals at BTNRH are free of all common pathogens.
All procedures for this study followed NIH guidelines and
were approved by Institutional Animal Care andUse Committees
(IACUC) of BTNRH, the Kresge Institute, and Washington
University.
PCR Arrays
To confirm the absence of transcription in the knockout mice, a
Qiagen (RRID:SCR_008539) custom RT2 Profiler
TM
PCR array
(SA Biosciences, Valencia, CA) and the Applied Biosystems
(Foster City, CA) 700 Sequence Detection System were used
to quantify transcription of all nAChR subunits measured in
the cochlear samples. Whole cochlear tissue from four WT,
4 α9 KOs and α10 KOs at age P10 were dissected in RNA
later R© (Life Technologies, Carlsbad, CA), and the tissue for each
genotype was combined for processing. RNA was extracted and
amplified using the recommended kits for the RT2 ProfilerTM
PCR arrays, including RNeasy, the RT2 First Strand kit, and RT2
SYBR green, all according to the manufacturer’s instructions.
We sequenced the resulting products identified in WT tissue
to confirm that the primers specifically recognized α9 and
α10. With this technique, it is not uncommon for primers to
recognize irrelevant transcripts in the absence of the intended
transcript, e.g., gene deletion. PCR products detected in the KO
samples were also sequenced and found to be multiple irrelevant
transcripts.
Auditory Brainstem Responses
For auditory brainstem response (ABR) measurements, animals
were anesthetized with amixture of ketamine and xylazine (80/15
mg/kg, IP) and placed dorsally in a custom head-holder with
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FIGURE 4 | (A) The schemata for the endogenous and recombined α9 nAChR loci and the Cre-mediated excised locus. (B) The Southern blot analysis of the α9 N2
generation. Genotypes of pups derived from the N2 breeding with Cre delete mice was determined by PCR as described in the Methods section. To confirm the
results of the PCR, the genomic DNA of five animals (#11625, #11618, #51654, #11855, and #11862) was tested by Southern blot. StuI digested DNAs were blotted
on nylon membrane and hybridized with the external 3′ probe (3E-J). The constitutive knockout line was established from #11862. The conditional knockout line was
established from #11625.
an ES-1 freefield speaker (Tucker-Davis Technologies) seven cm
directly lateral from the right ear. Subdermal platinum electrodes
(Grass) were placed behind the right pinna (reference), on the
vertex (active), and under the skin of the back (ground). A rectal
probe was used to monitor temperature, which was maintained
near 38◦C using a DC current-based isothermal pad (FHC).
Tonebursts 5 ms in duration (0.5ms cos2 R/F) were presented
500–1,000 times at 20/s in descending intensity using a 5 dB
minimum step size until wave I of the ABR could no longer be
visually discerned. The stimulus level was then increased until
the response re-appeared. Recording utilized Biosig32 and TDT
hardware. ABR thresholds were obtained at 5, 10, 20, 28.3, 40, and
56.6 kHz, 1 day, and 2 weeks after post-exposure by an operator
blinded to genotype.
Distortion Product Otoacoustic Emissions
For distortion product otoacoustic emissions recording, animals
were anesthetized as for ABRs in a separate session. DPOAE
recording was conducted using EMAV software (S. Neely, Z. Liu,
BTNRH) in conjunction with TDT and custom hardware. F2
varied from 5 to 40 kHz; F1 frequencies were given by F2/1.2. L1
and L2 were held constant at 75 and 65 dB SPL, respectively, and
calibrated in the ear canal using the calibration feature of EMAV.
Stimuli were digitally synthesized at 200 kHz and output to the
right ear using two TDT EC-1 speakers.
Noise Exposures
Broadband noise (4–45 kHz, 100 dB SPL) was produced and
filtered with General Radio 1310 generators and KrohneHite
3550 filters, respectively. The spectral shape of the noise was
as previously published (Ohlemiller et al., 1999). Two animals
at a time were placed in a wired cage suspended between four
speakers at 0, 90, 180, and 270 degrees azimuth in a single-walled
sound-proof booth with foam treatment (Industrial Acoustics,
Bronx, NY). The cage was rotated at 0.013 Hz during the
exposure to achieve a homogeneous sound field. The overall noise
level was measured oﬄine at the center of the cage using a B&K
4135 ¼ inch microphone in a combination with a B&K 2231
sound level meter set to broadband (0.2–70 kHz).
Efferent Mediated Adaptation
For efferent medicated adaptation of DPOAE experiments
(Halsey et al., 2005) was performed on animals anesthetized
with ketamine 65 mg/kg, xylazine 3.5 mg/kg, and acepromazine
2 mg/kg. Body temperature was maintained through the use
of water circulating heating pads and heat lamps. Additional
anesthetic (ketamine and xylazine) was administered if needed
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FIGURE 5 | The targeting strategy for the generation of the CHRNA10 knockout. Boxes represent exons. Solid line represents intronic sequences. LoxP and FRT
elements are shown as blue and red triangles, respectively. Neo and DTA boxes represent the neomycin positive selection cassette and the Diphtheria Toxin A
negative selection cassette. The constitutive KO was generated by breeding the floxed nAChR α9 heterozygous mice with Cre-expressing mice.
to maintain anesthesia depth sufficient to insure immobilization
and relaxation.
The stimuli were generated and the response data collected
using TDT System III hardware and a MATLAB
TM
script written
in-house. Stimulus tones F1 (10,909 Hz) and F2 (13,083 Hz)
were presented with a F2/F1 = 1.2 ratio, and the distortion
product (2F1–F2) recorded at 8,736 Hz. Tones were presented
via two EC1 drivers (TDT, aluminum-shielded enclosure made
in house) connected through a microphone (Knowles Acoustics
Itasca, IL electret condenser microphone, type FG-23329-P07,
in custom fabricated coupler with custom fabricated amplifier).
Responses for 12–14 F1 levels and 12 F2 levels for each
F1 level (for a total of 144–168 L1/L2 combinations) were
measured, starting with 1 dB intervals to localize the region of
maximum adaptation, and 0.4 dB intervals in that region of
maximum adaptation to fully map the region. For each level
combination, primaries were presented in 1-s bursts, with 10
ms on and off ramps. A 2-s pause followed every primary tone
presentation. Responses were collected with a sampling rate of
50 kHz. A fast Fourier transform (FFT) was performed on the
response waveform with an analysis window of 25 ms, and the
sound level of the distortion product was obtained for each
window. Responses to four 1-s identical stimulus presentations
were averaged.
Immunocytochemistry
All animals were perfused transcardially with 4%
paraformaldehyde, 0.1 M sodium phosphate, pH 7.4 for
5–10min, and post-fixed 6–16 h at 4◦C. Tissue samples were
rinsed and stored in phosphate buffer until shipment to Baylor
University for processing.
After dissection and isolation, each cochlea was decalcified,
microdissected into half-turns and then incubated in 5% normal
horse serum (NHS) with 0.3% Triton-X 100 in PBS for 1 h. This
was followed by incubation overnight to 48 h in primary antisera.
To label cholinergic efferent terminals, we used goat anticholine
acetyltransferse (ChAT) at 1:200 (EMD Millipore, Chemicon,
Tecumseh, CA; AB144P; RRID:AB_2079751). Hair cells were
either labeled with rabbit anti-myosin VIIa (Proteus Biosciences:
#25-6790; Ramona, CA) or stained with phalloidin (Alexa Fluor
488; ThermoFisher; #A12379; Grand Island, NY). The ChAT
antibody was labeled with a 1 h incubation in a biotinylated
secondary followed by 1 h in a streptavidin-conjugated Alexa
Fluor (ThermoFisher, #P10994). The myosin VIIa antibody was
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FIGURE 6 | Southern blot analysis for 5′ and 3′ homologous recombination in ES cells (α10 nAChR). The genomic DNA of the 10 tested ES cell clones was
compared with wild type DNA from 129ES. (A) Schematic representation of the WT and recombined α nAChR alleles with the relevant restriction sites for the
Southern blot analysis. (B) DNA was digested with Hpal/Nhel and blotted on nylon membrane and hybridized the external 407 bp 5′ probe (LA-E-C) or (C) DNA was
digested with HincII and hybridized to the internal 602 bp 3′probe (SA-I-T) to screen for the 5′ and 3′ homologous recombination. The external 407 bp 5′ probe was
generated by PCR on genomic DNA using the primer pair CTCTGTTTTCCTGTAGGTGG/GAAGGTAGGACTGGGTAAGG. The 5′ probe (LA-E-C) hybridized
downstream of the 5′ homology sequence of the targeting vector, which also allowed detection of the ES cell clones in which the targeting vector was integrated in a
non-homologous manner. The 602 bp internal 3′ probe (SA-I-T) was generated by PCR on genomic DNA using the primer pair GCCCTTACTTTATCCTTCCCCACA
TCG/CAGCTCCCTGAAATCCAGTTCCTGG. The expected size of the WT allele was10132 bp and the recombined allele 5,922 bp, respectively, with the 5′ probe and
9,567 and 5,024 bp, respectively, with the 3′ probe. Cell clones 1-1D, 1-1E, and 1-3C all showed WT and recombined signals of similar intensity and were chosen for
blastocyst injection.
labeled with a 1 h incubation in an Alexa Fluor secondary
(ThermoFisher, #A11035). Cochlear lengths were obtained for
each ear, and a cochlear frequency map computed to localize
hair cells. Confocal z-stacks of the 8.0 and 32.0 kHz regions
from each ear were obtained. Each stack spanned 80–100 µm
of cochlear length, and two adjacent stacks were imaged at each
locus. Images stacks were processed with Fiji Image Analysis
software (Schindelin et al., 2012).
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FIGURE 7 | (A) The schemata for the endogenous and recombined α9
nAChR loci. (B) The Southern blot analysis of the α10 F1 generation. The
genomic DNA of the two 80% chimeric F1 mice (#79717, #79718) from clone
1-1D was compared with C57BL/6J wildtype DNA. The HincII digested DNAs
were blotted on nylon membrane and hybridized with the internal 3′ probe
(SA-I-T) to validate the heterozygosity of the nAChR α9 gene mutation.
Statistical Analyses
The physiological data were analyzed with a one-way ANOVA
and Dunnett’s post-hoc individual comparisons between WT
controls with each of the KO groups. To determine if there was an
effect of age for the efferent adaptation studies, a linear regression
analysis was conducted on each group and all animals combined.
All statistical analyses were conducted using Prism 7 software
(GraphPad, San Diego, CA).
RESULTS
Generation of Conditional and Constitutive
KO Mice
The mouse CHRNA9 gene is located on chromosome 5 and
extends over 11-kb. It consists of 5 exons separated by 4 introns
(GenBank XM_132045). The ATG translation initiation site and
the Stop codon are located in exons 1 and 5, respectively.
CHRNA9 encodes for a 1,439 amino-acid open reading frame.
There are no alternative splice variants or cryptic exons known
for the mouse CHRNA9 gene. The mouse CHRNA10 gene
(GenBank AK033068) is located on chromosome 7 and extends
over 6-kb. It consists of 5 exons separated by 4 introns. The ATG
translation initiation site and the Stop codon are located in exons
1 and 5, respectively. CHRNA10 encodes for a 447 amino-acid
open reading frame. There are no alternative splice variants or
cryptic exons known for the mouse CHRNA10 gene. Nup98 is
located 2.5 kb upstream of the α10 gene.Art1 overlaps at the level
of exons 4 and 5, but the targeting strategy was not expected to
interfere with Art1 gene regulation.
FIGURE 8 | (A) The schemata for the endogenous and recombined α9 nAChR
loci and the Cre-mediated excised locus. (B) The Southern blot validation of
the α10 Heterozygous F1 or N2 generation. The genotype of the pups derived
from the F1 or N2 breeding with Cre deleter mice was determined by PCR as
described in the Methods section. To confirm the results of the PCR, the
genomic DNA of eight animals: WT (#29210, #29212), recombined (#29211,
#38053, #38057) and knockout (#29213, #38365, #38370). HincII digested
DNAs were blotted on nylon membrane and hybridized with the internal 3′
probe (SA-I-T). The constitutive knockout line was established from #38370.
The conditional knockout line was established from #38053.
We generated conditional and constitutive KOs for the α9 and
α10 subunits of the nAChR gene family on a congenic C57BL/6J
background. Our targeting strategy removed exons 1 and 2 of the
α9 gene and exons 1–3 in the α10 gene. Gene line transmission
was confirmed by PCR and Southern blot analyses, as described
in the methods section and in Figures 1–8.
The results of custom PCR arrays showed that the α9 and
α10 transcription in cochlea of the constitutive α9 and α10
KOs, respectively, was eliminated and there was no apparent
up-regulation by other nAChR subunits (Figure 9). In other
publications, we reported that α9 transcript was absent in the
retina of our α9 knockout (Smith et al., 2014), and that α9 and
α10 transcription was absent in vestibular tissue of the respective
constitutive KOs (Morley et al., 2017).
ABR and DPOAE Testing
We performed tests of cochlear function on WT (n = 23), α9
KO (n = 11), and α9α10 double KO (n = 13) mice between
2–3 months old. ABR and DPOAE measurements in WT
and KO mice were not statistically different for any of the
frequencies measured (Figures 10A,C), consistent with previous
studies suggesting that a dysfunction α9α10 nAChR does not
alter cochlear sensitivities. There is evidence that the MOC
efferent pathway provides some protection against noise-
induced cochlear injury (Maison et al., 2013). The strength
of MOC efferent protection and the physical number of the
OHC nAChRs present in the inner ear both have been directly
correlated with individual susceptibility to noise-induced hearing
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FIGURE 9 | PCR arrays. Whole cochlear tissue was combined from four animals and the expression levels were determined with a custom Nicotinic Acetylcholine
Receptor Qiagen RT2 Profiler
TM
PCR array. The transcripts for the α9 and α10 subunits in wild type mice were verified by sequencing. The small amount of product
that was recognized by the primers in the KOs was also sequenced and were multiple irrelevant transcripts. There was no obvious change in transcription level of the
other nAChRs that were detected in the cochlear tissues with this method.
loss, whereas overexpression of the OHC efferent receptor has
been shown to be protective against noise-induced hearing
loss (Maison and Liberman, 2000; Luebke and Foster, 2002;
Maison et al., 2002). We investigated whether our KO mice
would show altered responses to noise. WT (n = 18), α9 KO
(n = 11), and α9α10 double KO (n = 10) mice were exposed
for 2 h to broadband noise (4–45 kHz) at 100 dB SPL. ABR and
DPOAE measurements were repeated post noise exposure to
assess protection from noise in the KO mice. After 2 weeks, ABR
threshold shifts ranged from <10 dB at low frequencies and
as high as 50 dB at higher frequencies. Similarly, DPOAE level
shifts ranged from around 5–15 dB for low frequencies (5–10
kHz) and as high as 40–50 dB for higher frequencies. Overall,
neither α9KO nor α9α10 KO mice showed any significant loss
of protection from noise (see Figures 10B,D). Although ABR
threshold shifts were similarly affected in all animals, DPOAE
level shifts generated slightly varying patterns dependent on
frequency. The greatest differences in DPOAE level shifts
between genotypes were between 15 and 20 kHz. However, a
one-way ANOVA for F2 frequencies between 15 and 20 kHz did
not show any significant difference in DPOAE shift betweenWT,
α9 KO, and α9α10 KO (p < 0.05).
Efferent Mediated Adaptation
Efferent-mediated adaptation of the DPOAE is a non-invasive
measure of efferent function that has been shown to be
a predictor of sensitivity to noise-induced trauma (Maison
and Liberman, 2000; Halsey et al., 2005). Efferent mediated
adaptation was determined in WT controls (n = 37), α9 KO
(n = 19), α10 KO (n = 11), and α9α10 KO (n = 18) animals.
Adaptation magnitude was similar for all groups, with the α9α10
KO mice having slightly higher values (Figure 11A). However, a
one-way ANOVA showed that there was a significant difference
between the WT controls and KOs [F(3, 81) = 4.33, p < 0.01].
Using Dunnett’s postdoc comparisons, only the α9α10 KO group
was significantly different from controls (p < 0.01). Thus, the
results of the efferent-mediated adaptation DPOAE experiments
showed that neither the deletion of α9 or α10 subunits alone
produced a significant decrement in efferent adaptation, but the
deletion of both subunits did result in a significant decrement
(Figure 11A). Anesthesia may attenuate the strength of the
medical olivocochlear reflex (Chambers et al., 2012) and the
differences betweenWT and KOs might be larger in anesthetized
mice. The C57BL/6J strain carries an age-related hearing loss
locus that affects hearing. Additionally, 1–3month oldmice show
a developmental delay in suprathreshold sound-evoked activity
of the auditory nerve (Dickerson et al., 2016). In order to show
age was not related to the results obtained here, the animals were
tested at a young age and efferent mediated adaptation scores
were plotted as a function of age. A linear regression analysis
was performed on each group and all of the animals combined.
There was no significant relationship between age and adaptation
magnitude for any group or the animals combined (r= 0.05). The
combined regression plot is shown in Figure 11B.
Efferent Innervation Patterns
Previous studies of single α9 and α10 KOs show that the efferent
innervation in the OHC region is abnormal (Vetter et al., 1999,
2007). We investigated whether the α9α10 KOs had abnormal
innervation patterns that differed from the single subunit KO.
We focused our investigation of the efferent innervation in
α9 KO mice and α9α10 KO mice at two ages: postnatal days
(P) 10–11 (just prior to the onset of hearing) and 1 month.
In basal (high frequency) regions of the WT cochlea, efferent
fibers and terminals travel in the inner spiral bundle (ISB)
and give rise to tunnel crossing fibers (TCFs) that terminate
as OHC efferent endings (Figures 12A,D). At P11, the ISB
is a highly branched plexus with terminals surrounding the
basal portions of inner hair cells (IHCs). The OHC efferent
innervation in young postnatal animals consists of dense
irregularly shaped and highly branched clusters of cholinergic
terminals (Figure 12A). In the 1-month old WT, the ISB is a
densely labeled bundle with fewer terminals surrounding IHCs.
The cholinergic terminals below OHCs are regularly arrayed
by OHC row, larger terminal cluster sizes (Figure 12D). The
cholinergic innervation differed substantially in the single and
double KO at both ages (Figures 12B,C,E,F). In the α9 KO at
P11, cholinergic terminals and fibers are intensely labeled in the
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FIGURE 10 | In vivo assays of hearing thresholds. (A) Plotted are the mean (±s.e.m.) ABR thresholds of pre-noise exposures for 2-month-old wild-type (WT, n = 23,
gray open squares), α9 KO mutants (n = 11, white filled circles) and α9α10 KO mutants (n = 13, black filled circles). (B) ABR threshold shift (dB) at each frequency
tested for wild-type (n = 18, gray open squares), α9 KO mutant (n = 11, white filled circles), and α9α10 KO mutant (n = 11, black filled circles) mice. (C) Mean
(±s.e.m.) DPOAE levels as a function of f2 frequencies for 2-month-old wild-type (WT, n = 7, gray open squares), α9 KO mutants (n = 10, white filled circles), and
α9α10 KO mutants (n = 8, black filled circles). The mean (±s.e.m.) noise floor for each genotype is also plotted for wild-type (WT, n = 7, red open squares), α9 KO
mutants (n = 10, gray filled triangles), and α9α10 KO mutants (n = 8, gray open triangles). (D) Mean (±s.e.m.) DPOAE shift (dB) across all f2 frequencies for wild-type
(gray open squares), α9 KO mutant (white filled circles), and α9α10 KO mutant (black filled circles) mice.
FIGURE 11 | (A) Efferent mediated adaptation of DPOAE. Although there was a significant overall group effect [F (3, 81) =4.33; p < 0.01], there was not a significant
difference between wild type and either α9 or α10 knockouts. Only the double (α9α10) knockout group had significantly lower adaptation scores (p < 0.01). (B) The
animals were tested as a young age (26–82 days) to avoid effects attributable to the ahl (age-related hearing loss) locus carried by C57BL/6J mice. There was not a
correlation between adaptation scores and age in this study (r = 0.051).
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FIGURE 12 | Confocal projections of cholinergic innervation patterns from middle regions (15–20 kHz) of the mouse cochlea. (A) In the wildtype (WT) animal at P11,
ChAT-labeled efferent fibers and terminals are found below inner hair cells (IHCs) and in the inner spiral bundle (ISB). Thick ChAT-labeled efferent fibers cross the tunnel
of Corti (TCFs) and terminals contact outer hair cells (OHCs) in rows 1, 2, and 3. (B) In the α9 KO mutant at P11, ChAT-labeling is more robust below IHCs but more
sparse below OHCs. Very thin ChAT-labeled efferent fibers are seen crossing the tunnel of Corti. (C) In the α9α10 KO mutant at P11, ChAT-labeling is more robust
below IHCs but more sparse below OHCs. Very thin ChAT-labeled efferent fibers are seen crossing the tunnel of Corti. (D) In the WT at 1 month, ChAT-labeling is
found below IHCs in the ISB and large terminal clusters are seen on OHCs. ChAT-labeled efferent fibers cross the tunnel of Corti. (E) In the α9 KO mutant at 1 month,
ChAT-labeling is found below IHCs. Thick ChAT-labeled efferent fibers cross the tunnel of Corti. Compared to WT, ChAT-labeled OHC terminal clusters are smaller with
smaller individual terminals. (F) In the α9α10 KO mutant at 1 month, the ISB has ChAT-labeled fibers and terminals below IHCs OHC terminal clusters are smaller than
WT but have larger individual terminals than in the α9 KO. ChAT-labeled efferent fibers cross the tunnel of Corti.
ISB, however, TCFs are thin and OHC efferent terminals are
weakly labeled with small terminals compared to WT. In the
α9α10 KO at P11, the ISB is also intensely labeled and TCFs were
thinner and fewer in number than in WT. There were also fewer
cholinergic terminals and the size of the terminal clusters was
much smaller than in WT mice. At 1 month, the ISB in α9α10
was similar to WT as well as the OHC terminals were highly
arrayed. Unlike WT, the terminal cluster sizes were smaller and
more similar to the α9 KO.
DISCUSSION
The knockout models for the α9 and α10 nAChR subunits
on a C57BL/6J background will have wide application for the
study of their function in diverse tissues. The mouse models
were generated by deletion of exons 1–2 in the α9 and 1–3
in α10, and their associated introns, eliminating activity and
proper folding in both genes. The strains were backcrossed onto
a C57BL/6J background because it is the most common genetic
background used for mouse models, and would therefore allow
the easy development of double or triple KOs. The constitutive
KOs generated by crossing α7, α9, and α10 are viable and
fertile.
In this manuscript we reported the auditory characterization
of the α9, α10, and α9α10 double knockouts. The α9α10 nAChR
mediates the neurotransmission of theMOC efferent system. The
MOC system innervating the OHCs constitutes a sound-evoked
reflex pathway that is excited by sound in either ear (Folsom
and Owsley, 1987; Liberman, 1989). In all species investigated,
activation of the MOC system decreases cochlear sensitivity. In
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the present study, the most notable finding is that the deletion
of both α9 and α10 subunits was required before a significant
decrement was observed in efferent strength, i.e., the magnitude
of the loss of cochlear sensitivity. The results suggest that neither
subunit alone is capable of maintaining efferent activity in this
paradigm.
The results are somewhat at odds with previous data obtained
using a α9 KO generated by the deletion of exon 4 (and its
flanking intronic sequences) and backcrossed onto a mixed
CBA/CaJ X 129Sv background. In initial studies, it was concluded
that the deletion of α9 was sufficient to render the α9α10
nAChR incapable of carrying current (Vetter et al., 2007; Taranda
et al., 2009). Subsequent studies comparing α9 KOs with WTs
(e.g., Mohammadi and Christie, 2014; Terreros et al., 2016;
Mohammadi et al., 2017; Tu et al., 2017), have typically not used
α10 KO mice, but presumed that deletion of α9 is equivalent to
a deletion of the α9α10 receptor. Thus, any contribution of α10
would not have been detected.
The results reported here, however, are consistent with our
studies of the vestibular system in ourmousemodels.We recently
reported the analysis of vestibular sensory evoked potentials
(VsEPs) in α9, α10, α9α10, α7, and α7α9 knockouts (Morley
et al., 2017). The results were complex. As in the experiment
reported here, however, the most affected phenotype was the
α9α10 double KO; the α9 single KO did not recapitulate
the α9α10 KO. Unexpectedly, the α10 KO had a phenotype
different from the WT, α9, or the α9α10; moreover, the α10
KO phenotype was similar to the α7 KO, indicating that
perhaps α7 and α10 could be assembled in cells relevant to the
vestibular phenotype. Co-expression and spatial localization of
α7 and α10 was previously reported in the sympathetic neurons
(Lips et al., 2006).
In other reports, we reported the phenotypes of the α9, α10,
α9α10, and α7α9 knockouts in an Experimental Autoimmune
Encephalitis (EAE) model of Multiple Sclerosis using our KO
models (Simard et al., 2013; Liu et al., 2017). There was no
difference between α9 and α9α10 KOs in the EAE model, but the
α7α9 differed from the α7 or α9 KO.
The disorganization of the cholinergic MOC innervation in
the cochlea observed in our mouse models is similar to that
reported by others in α9 and α10 KOs (Vetter et al., 1999,
2007). We did not quantify the results and therefore any subtle
differences would not have been detected. At least at the gross
level, however, there were some minor morphological differences
in the efferent innervation between the α9, α10, and α9α10 KO
and all differed from WT suggesting that different combinations
of subunit loss may be capable of slight alterations in the
development of efferent innervation patterns.
Differences in the physiology (this report; Morley et al.,
2017) between our α9 and α10 constitutive KO mice and the
models first described by Elgoyhen et al. (1994, 2001) may
be attributable to genes in the background strains that could
modify the phenotypes. Unlike earlier lesioning experiments,
behavioral thresholds of the previous α9 KO model did not show
any performance deficits in the presence of background noise
(May et al., 2002). It is also now known that α9 and α10 are
among the nAChRs that mediate metabolic signaling (Richter
et al., 2016; Backhaus et al., 2017; Zakrzewicz et al., 2017).
Epigenetic differences may also be a factor; the α10 gene has
CpG islands within the body of the gene (although α9 does not).
Few laboratories control genetic drift, many do not maintain
pathogen-free laboratories, and the environmental noise is not
always monitored. These are factors, usually unknown and/or
unreported, that can affect phenotypes. Finally, we expect that
double and multiple KOs and conditional KOs will shed light on
the complex relationship among nAChRs in many systems.
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